How do I measure brachial‑ankle pulse wave velocity (baPWV)?

How to Measure Brachial-Ankle Pulse Wave Velocity (baPWV)

Brachial-ankle pulse wave velocity is measured using automated oscillometric devices that place four blood pressure cuffs simultaneously on both arms (brachial) and both ankles, with ECG leads attached to the chest for timing synchronization. 1

Equipment and Setup

The measurement requires specialized automated devices, with the most commonly used being:

• VP1000/VP2000 (Omron Healthcare) - the standard device used extensively in Asian populations 1
• Vasera (Fukuda Denshi) - uses phonocardiography for timing 1
• abiPWV - a validated alternative device 2

Measurement Procedure

Patient Positioning

• Place the patient in the supine position - this is the standard measurement position 3
• Allow 5-10 minutes of rest before measurement
• Note that baPWV values are significantly lower in supine position compared to sitting or standing positions (P < 0.01), so position must be standardized 3

Device Application

1. Apply four oscillometric cuffs: one on each arm (brachial) and one on each ankle 1
2. Attach ECG leads to the chest for cardiac timing 1
3. For Vasera device: additionally tape a small phonocardiographic microphone onto the chest 1
4. Enter patient data: age, height, and gender into the software (distance calculations use statistical norms, primarily based on Japanese populations) 1

Measurement Process

• The device simultaneously records pulse wave arrival at all four limbs using oscillometric detection 1
• The ECG QRS complex or heart sounds provide the cardiac timing reference 1
• The system automatically calculates the time delay between pulse wave arrival at the brachial and ankle sites 1
• Distance is estimated by the software based on patient demographics 1
• baPWV is calculated automatically as distance/time delay 4

Technical Considerations

Reproducibility

The within-observer coefficient of variation is 6.5% ± 4.1%, and between-observer is 3.6% ± 3.9%, indicating good reproducibility 4

Important Limitations

Critical caveat: While baPWV has demonstrated prognostic value for cardiovascular disease in Asian populations 5, it measures a mixed arterial pathway including both elastic (aortic) and muscular (peripheral) arteries 5. This creates "uninterpretable ambiguity" in what the measurement actually represents regarding aortic stiffness 5. The large distance from measuring sites to the aorta makes it "virtually impossible to reconcile how derived values effectively relate to aortic pulse wave velocity" 5.

Clinical Utility Despite Limitations

Despite these theoretical limitations, baPWV has proven clinical value:

• A 1 m/s increase in baPWV associates with 12% increased cardiovascular event risk 6
• It consistently increases with most traditional cardiovascular risk factors (except dyslipidemia) 6
• The device simultaneously provides ankle-brachial index (ABI), allowing identification of peripheral arterial disease when ABI < 0.9 1

Comparison to Gold Standard

baPWV correlates moderately with carotid-femoral PWV (r = 0.755), but Bland-Altman analysis shows significant differences between the two techniques across the measurement range 4. When both are compared for predicting increased carotid intima-media thickness, carotid-femoral PWV shows stronger associations, particularly in males, those ≥65 years, and those with cardiovascular risk factors 7.

Practical Advantages

The fully automated nature, ease of use, and simultaneous ABI measurement make baPWV particularly suitable for screening in clinical practice, especially in aged populations with multiple cardiovascular risks 6. The measurement takes approximately 5 minutes once the patient is positioned and cuffs are applied.